PBE

PowerShares Dynamic Biotechnology & Genome Portfolio
CLOSING PRICECHANGE (%)VOLUME
$43.80-- (--)12.52K
4:00:00 p.m. (ET) 02/27/2017
PRE-MARKET SESSION
LAST TRADECHANGE (%)
---- (--)
BID SIZEBID ($)ASK ($)ASK SIZE
--------

Overall Rating

B

60
as of 02/27/17

Rating Details

90
78
60
Segment Average
  • Overview
  • Efficiency
  • Tradability
  • Fit

PBE Fund Description

The PowerShares Dynamic Biotechnology & Genome Portfolio ETF tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.

PBE FactSet Analytics Insight

As is evident from its name, PBE goes beyonda unique portfolio of biotech and peripheral-industry companies the scope of pure biotech firms, which causes PBE to differ substantially from other biotech ETFs and our segment benchmark. Only about 1/2 of its holdings overlap those of our biotech benchmark. Moreover, far from a plain-vanilla approach, PBE's underlying index uses a multifactor system (fundamental and technical factors) to select stocks and a tiered equal-weighting system to construct its portfolio. The approach produces a unique portfolio of biotech and peripheral-industry companies. PBE is one of the least liquid biotech ETFs but, in a highly liquid segment, that still translates to penny-wide spreads and ample block liquidity. While PBE's sizeable fee generates a strong headwind to tracking, it generally recovers some of its expense and overall lags its index by less than its fee.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

PBE Top 10 Countries

PBE Top 10 Sectors

PBE Top 10 Holdings View All

PBE Summary Data

06/23/05
Open-Ended Fund
0.58%
$236.32 M
$841.42 K
0.26%

PBE Portfolio Data

$22.06 B
-1,267.57
5.67
0.35%
03/17/17
30

PBE Index Data

Dynamic Biotechnology & Genome Intellidex Index
Tiered
Multi-Factor
Thomson Reuters US Biotechnology & Medical Research

Related ETFs to PBE

N/A
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

PBE Portfolio Management

0.58%
0.32%
0.41%
0.02%

PBE Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

PBE Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
------
------
------
------
------
------
------
------
------
------
Bats BZX Real-time Quote - 09:25:01
Average Spread
Premium/Discount
Volume

PBE FactSet Analytics Block Liquidity

As of 02/27/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of PBE. PBE is rated a 5 out of 5.

PBE Tradability

20,645
$841.42 K
17,259
$719.74 K
0.26%
$0.11
-0.05%
0.24% / -0.18%
None
100.00%
50,000
0.35
0.02%
0.36%
--
$42.39
5

PBE Performance Statistics

0.89
1.18
1.14
1.12
0.67%
Thomson Reuters US Biotechnology & Medical Research